Obstructive sleep apnoea (OSA) makes it particularly challenging to get ‘good’ sleep and is a very common condition in modern society, men are slightly more susceptible than women and the likelihood increases drastically with age. A study in 2021 by the American Academy of sleep medicine revealed that 57.7% of males in the enrolled age group of 57 – 75 had some degree of sleep apnoea, with 20.2% moderate-severe, compared to 41.7% of females having some degree of sleep apnoea and 10.0% moderate-severe.
When it comes to PAP therapy (widely regarded as the gold standard of this common condition of OSA, as well as other respiratory conditions), we believe long-term success and optimum treatment outcome is consistently achieved through a practical test & trial process fine-tuned & tailored to an individual’s experience & needs by a trained professional. Listening to user feedback about treatment experience is very important in order to achieve the delicate balance and unearth the attention to detail that is required to get it right.
When asked what defines successful treatment specifically with sleep apnoea, the usual metric clinicians & specialists refer to and train patients/users to look out for is AHI (Apnoea Hypopnea Index) per hour. A score of less than 5 AHI/hr is the typical theoretical definition of clinical effectiveness in PAP therapy. In reality, therapy outcome revolves around far more than AHI/hr. The balance and suitability of pressure settings is particularly influential as well as a variety of comfort factors, mask fit, and a myriad of lifestyle factors that impact both sleep & treatment quality. The chart graphic (left) offers insight into how Santé & Löwenstein view therapy success as an interconnected series of key factors, which logically centre around a comfortable & recuperative treatment (i.e. restorative sleep), whereby patients are motivated & happy to comply so that the loop of therapy success remains unbroken.
The following are seven key clinical features that belong to Löwenstein devices, that mainly delve into deeper and further concepts than just the AHI index. We refer to these as the Löwenstein Difference, delivering that edge in quality of the treatment and outcome.
I was a long time autoCPAP (APAP) user and from the first day of using the Löwenstein device I knew something was special, I jumped out of bed feeling distinctly energetic and more refreshed than the usual experience after using my other sleep device.Peter – Paramedic
With appropriate APAP settings, the Prisma20A worked like a charm. I felt rested in the morning, something I hadn’t felt for quite a while, and the need for a nap in the afternoon virtually disappeared.A/Prof Richard Gates, retired neuroscientist and sleep researcher